CLINICAL_TRIALS
trial_result
· 2017-09-06
Clinical Trial Update: Tysabri Effects on Cognition and Neurodegeneration in Multiple Sclerosis [NA]
Summary
A completed clinical trial studied the effects of natalizumab (Tysabri) on cognition and neurodegeneration in multiple sclerosis, with results posted in 2017.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Chicago | Conditions: Multiple Sclerosis | NA | Status: COMPLETED | Results posted: 2017-09-06